Page 61 - Sputnik News Today

India has become the 60th country to approve Sputnik V Sputnik V is one of only three vaccines registered in India The Russian vaccine has been approved for use in countries with

The Russian Direct Investment Fund said that India has given authorization for the use of Russia's Sputnik V coronavirus vaccine. India's central drug regulator is yet to make a statement.

Top government sources told ANI that by end of the third quarter of this year, India will be getting vaccines from five additional manufacturers

Belarus' health ministry said on Thursday the country had started mass producing Russia's Sputnik V vaccine and planned to produce up to 500,000 doses of the shot per month.

Russia Pledges To Guarantee Vaccine Supply To Argentina Argentine president receives phone call from his Russian counterpart in which he ensured supply of Sputnik V vaccine. Russian President Vladimir Putin promised Monday to guarantee coronavirus vaccine supplies to Argentina in a phone call with the countrys leader. Putin spoke with President Alberto Fernandez to guarantee the vaccine supplies and to check on Fernandezs health after ...

Watchdog: Lebanons vaccination of refugees, migrants lags Sign In SARAH EL DEEB, Associated Press April 6, 2021 FacebookTwitterEmail 11 1of11A woman receives a Pfizer COVID-19 vaccine at Saint George Hospital University Medical Center, in Beirut, Lebanon, Tuesday, April 6, 2021. Human Rights Watch, a leading rights group, said that Lebanons vaccination campaign has been slow and risks leaving behind some of the countrys most vulnerable people, including Palestinian and Syrian refug...

Dr Reddys strong product pipeline and other factors that make it stock pick of the week Synopsis DRL continues to generate free cash flows (FCFs) due to strongholds in some legacy drugs. Its lower valuation compared to its peers and strong balance sheet, are the other factors that have made the company a favourite of analysts. Dr Reddy’s Lab (DRL) has reported a decent set of numbers for the third quarter of 2020-21. Its aggregate revenue grew 12% y-o-y; with domestic, US and Europe revenues ...

DRL continues to generate free cash flows (FCFs) due to strongholds in some legacy drugs. Its lower valuation compared to its peers and strong balance sheet, are the other factors that have made the company a favourite of analysts.

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russias Sputnik V COVID-19 vaccine annually.

Gamaleya director claims Sputnik Light reduces contagion Gamaleya director claims Sputnik Light reduces contagion Moscow, Apr 4 (Prensa Latina) The use of Russias Sputnik Light vaccine halves the risk of contagion with the SARS CoV-2 coronavirus, which causes Covid-19, Alexander Gintsburg, director of the Gamaleya Epidemiology and Microbiology Center, claimed on Sunday. The scientist told Russia 1 channel that if the Light option is used, Sputnik V vaccines first component, without the second...